PAR PHARMACEUTICAL, INC. v. HOSPIRA, INC.

No. 2020-1273.

PAR PHARMACEUTICAL, INC., PAR STERILE PRODUCTS, LLC, ENDO PAR INNOVATION COMPANY, LLC, Plaintiffs-Appellees. v. HOSPIRA, INC., Defendant-Appellant.

United States Court of Appeals, Federal Circuit.

Decided: November 23, 2020.


Attorney(s) appearing for the Case

DANIEL BROWN , Latham & Watkins LLP, New York, NY, argued for plaintiffs-appellees. Also represented by JENNIFER KOH , San Diego, CA; GABRIEL BELL , Washington, DC.

THOMAS J. MELORO , Willkie Farr & Gallagher LLP, New York, NY, argued for defendant-appellant. Also represented by DEVON WESLEY EDWARDS , MATTHEW S. FREIMUTH .

Before DYK, TARANTO, and STOLL, Circuit Judges.


NOTE: This disposition is nonprecedential.

The plaintiffs (collectively, Par) own and have exclusive rights to U.S. Patent Nos. 9,119,876 and 9,295,657, which claim particular compositions containing epinephrine, the active ingredient in Par's Adrenalin® products, as well as methods of administering such compositions...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases